Subbiah, M T R (2002) Estrogen replacement therapy and cardioprotection: mechanisms and controversies. Braz J Med Biol Res 35:271-6
|
Subbiah, M T Ravi; Abplanalp, William (2002) Evidence of increased formation of products retaining strong antioxidant activity from estradiol-17beta oxidation in the presence of human plasma lipoproteins. J Lab Clin Med 139:357-63
|
Scheiber, M D; Liu, J H; Subbiah, M T et al. (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8:384-92
|
Abplanalp, W; Ravi Subbiah, M T (2001) Uptake and protection against oxidative stress by estrogen esters in THP-1 human macrophage cell lines. Gynecol Obstet Invest 51:81-4
|
Abplanalp, W; Scheiber, M D; Moon, K et al. (2000) Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens. Eur J Endocrinol 142:79-83
|
Abplanalp, W; Rymaszewski, M; Adamski, J et al. (1999) Evidence for interference in estradiol-17beta inactivation to estrone by oxidized low-density lipoprotein and selected lipid peroxidation products. J Lab Clin Med 134:253-9
|
Ayres, S; Baer, J; Subbiah, M T (1998) Exercised-induced increase in lipid peroxidation parameters in amenorrheic female athletes. Fertil Steril 69:73-7
|
Ayres, S; Abplanalp, W; Liu, J H et al. (1998) Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage. Am J Physiol 274:E1002-8
|
Subbiah, M T (1998) Mechanisms of cardioprotection by estrogens. Proc Soc Exp Biol Med 217:23-9
|
Tang, M; Abplanalp, W; Subbiah, M T (1997) Association of estrogens with human plasma lipoproteins: studies using estradiol-17beta and its hydrophobic derivative. J Lab Clin Med 129:447-52
|
Showing the most recent 10 out of 15 publications